BMP-2 Dispute Turns Nasty (MedPageToday)
Spine Journal Takes Aim at Infuse Research (MedPageToday)
Review faults Medtronic spine device studies (Minneapolis StarTribune Business)
SPINE EXPERTS SAY MEDTRONIC STUDIES BIASED (Memphis Commercial Appeal)
The dispute over adverse effects associated with bone morphogenetic protein-2 (BMP-2) in spinal fusion procedures has turned ugly for the editors of two leading orthopedics journals, with thinly veiled insults flying between them in an unusual public exchange of letters.
Squaring off are Thomas Zdeblick, MD, head of the University of Wisconsin's orthopedics and rehabilitation department, and Eugene Carragee, MD, chief of spinal surgery at Stanford University.In the letters, Zdeblick hints that Carragee is a poor surgeon, while Carragee accuses Zdeblick of numerous falsehoods and pandering to the media.
The letters are to be published July 12 online in The Spine Journal, which Carragee edits.
A spokesperson for the North American Spine Society, which publishes the journal, said Zdeblick's letter is slated for imminent online publication; Carragee's response will be posted late next week.
However, both were quietly made available June 30 ...
